Position in PFE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$200,520,541
-$37,370,804 QoQ
Shares Held
8,327,265
-1.7% QoQ
Ownership
0.146%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#65
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KBC Group NV holds $2,157,048,254 across 10 Drug Manufacturers - General names. PFE ranks #5 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
544,998 | $653,687,004 | |
| 2 | JNJ |
Johnson & Johnson
|
1,322,168 | $335,791,005 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
4,264,357 | $245,712,249 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,644,035 | $207,707,380 | |
| 5 | PFE |
Pfizer Inc
This page
|
8,327,265 | $200,520,541 | |
| 6 | ABBV |
AbbVie Inc.
|
672,932 | $169,336,607 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,131,286 | $145,370,250 | |
| 8 | AMGN |
Amgen Inc
|
382,676 | $138,574,632 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $200,520,541 | 8,327,265 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $237,891,345 | 8,471,914 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $228,923,452 | 9,193,713 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $216,256,071 | 8,487,287 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $82,927,148 | 3,421,087 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $88,718,000 | 3,501,105 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $87,585,318 | 3,301,369 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $89,871,230 | 3,105,433 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $68,983,233 | 2,465,448 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $278,682,898 | 10,042,627 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $125,986,104 | 4,376,037 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $103,797,819 | 3,129,268 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $109,480,482 | 2,984,746 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $151,562,615 | 3,714,770 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $200,171,314 | 3,906,544 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $180,333,471 | 4,120,966 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $213,031,582 | 4,063,162 | Shares | Defined | 2024-02-14 | |
| 2022-03-31 | $175,566,461 | 3,391,278 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $165,351,337 | 2,800,192 | Shares | Defined | 2024-02-14 | |
| 2021-09-30 | $87,541,951 | 2,035,386 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $62,678,908 | 1,600,585 | Shares | Defined | 2022-02-15 | |
| 2021-03-31 | $48,542,729 | 1,339,849 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $41,310,427 | 1,122,261 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $46,391,652 | 1,264,079 | Shares | Defined | 2022-02-14 | |
| 2020-06-30 | $96,643,543 | 2,955,457 | Shares | Defined | 2022-02-14 | |
| 2020-03-31 | $98,947,959 | 3,031,498 | Shares | Defined | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||